A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India

Upinder Kaur, Bisweswar Ojha, Bhairav Kumar Pathak, Anup Singh, Kiran R Giri, Amit Singh, Agniva Das, Anamika Misra, Ashish Kumar Yadav, Sankha Shubhra Chakrabarti, Sangeeta Kansal
doi: https://doi.org/10.1101/2021.04.03.21254823

Article usage

Article usage: April 2021 to November 2024

AbstractFullPdf
Apr 20219623237
May 20213691889
Jun 20211921295
Jul 2021133551
Aug 20211361223
Sep 202194527
Oct 202178428
Nov 202160529
Dec 202153427
Jan 202243627
Feb 20222708
Mar 20223405
Apr 202240316
May 202223318
Jun 2022413104
Jul 202219176
Aug 20222129
Sep 20222819
Oct 202241113
Nov 20221215
Dec 202215115
Jan 202320414
Feb 202317712
Mar 20231919
Apr 202324113
May 202311210
Jun 202310411
Jul 20237112
Aug 2023151012
Sep 202313410
Oct 2023908
Nov 202317515
Dec 20239110
Jan 2024827
Feb 20241628
Mar 20241225
Apr 202416816
May 20246212
Jun 202414117
Jul 20241218
Aug 202417520
Sep 202416215
Oct 20247214
Nov 2024302
Back to top
Posted April 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India
Upinder Kaur, Bisweswar Ojha, Bhairav Kumar Pathak, Anup Singh, Kiran R Giri, Amit Singh, Agniva Das, Anamika Misra, Ashish Kumar Yadav, Sankha Shubhra Chakrabarti, Sangeeta Kansal
medRxiv 2021.04.03.21254823; doi: https://doi.org/10.1101/2021.04.03.21254823
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area